Dr. Lecht recently joined the CannRx team to lead the R&D. Â He is an experienced multidisciplinary basic and translational researcher. Dr. Lecht brings along a valuable experience in pre-clinical project management from early discovery to clinical trials. Prior to joining CannRx, Dr. Lecht took a leading part in several botanical drug development projects, provided regulatory services to bio-tech start-up companies towards first interaction with FDA and co-founded a pharmaceutical consulting company.
Dr. Lecht completed a post-doctoral training in Regenerative Medicine (Temple University, PA), holds a PhD and an MSc in Pharmacology from the Hebrew University in Jerusalem and is a licensed pharmacist in Israel.
Dr. Lecht published numerous peer-reviewed publications and presented at dozens of international meetings and conferences.